Addition of sodium criterion to SOAR stroke score. (10th July 2016)

• Record Type: Journal Article
• Authors: Adekunle‐Olarinde, I. R.; McCall, S. J.; Barlas, R. S.; Wood, A. D.; Clark, A. B.; Bettencourt‐Silva, J. H.; Metcalf, A. K.; Bowles, K. M.; Soiza, R. L.; Potter, J. F.; Myint, P. K.
• Is Part Of: Acta neurologica Scandinavica. Volume 135:Number 5(2017:May)
• Page Start: 553
• Page End: 559
• Publication Date: 2016-07-10
• Subjects: acute stroke -- dysnatremia -- mortality -- prognosis; Neurology -- Periodicals; 616.8
• DOI: 10.1111/ane.12634
• Languages: English
• ISSNs: 0001-6314

Abstract

Abstract : Objectives: To examine the usefulness of including sodium (Na) levels as a criterion to the SOAR stroke score in predicting inpatient and 7‐day mortality in stroke. Materials and Methods: Data from the Norfolk and Norwich University Hospital Stroke & TIA register (2003–2015) were analysed. Univariate and then multivariate models controlling for SOAR variables were used to assess the association between admission sodium levels and inpatient and 7‐day mortality. The prognostic ability of the SOAR and SOAR Na scores for mortality outcomes at both time points were then compared using the Area Under the Curve (AUC) values from the Receiver Operating Characteristic curves. Results: A total of 8493 cases were included (male=47.4%, mean (SD) 77.7 (11.6) years). Compared with normonatremia (135–145 mmol/L), hypernatraemia (>145 mmol/L) was associated with inpatient mortality and moderate (125–129 mmol/L) and severe hypontraemia (<125 mmol/L) with 7‐day mortality after adjustment for stroke type, Oxfordshire Community Stroke Project classification, age, prestroke modified Rankin score and sex. The SOAR and SOAR‐Na scores both performed well in predicting inpatient mortality with AUC values of .794 (.78–.81) and .796 (.78–.81), respectively. 7‐day mortality showed similar results. Both scores were less predictive in those with chronic kidney disease (CKD) and more so in those with hypoglycaemia. Conclusion: The SOAR‐Na did not perform considerably better than the SOAR stroke score. However, the performance of SOAR‐Na in those with CKD and dysglycaemias requires further investigation.